Omada shares open at $23 in Nasdaq debut after health-tech company’s IPO

Omada shares open at  in Nasdaq debut after health-tech company’s IPO


Omada Health CEO Sean Duffy on IPO debut: Today is the right moment for us

Omada Health shares popped more than 30% in their Nasdaq debut on Friday after the virtual chronic care company priced its stock at $19 per share in its IPO.

The stock opened at $23 and quickly hit $25.

The company said in a press release late Thursday that it sold 7.9 million shares in the offering, amounting to about $150 million. The pricing was in the middle of the expected range, and valued the company at just over $1 billion, though that number could be higher on a fully diluted basis.

Omada, founded in 2012, is trading under ticker symbol “OMDA.” The company offers virtual care programs to support patients with chronic conditions like prediabetes, diabetes and hypertension. Sean Duffy, Omada’s CEO, co-founded the company with Andrew DiMichele and Adrian James, who have both moved on to other ventures.

More CNBC health coverage

It’s the second digital health IPO in a matter of weeks following an extended drought for the industry. Digital physical therapy startup Hinge Health debuted on the New York Stock Exchange in May. Hinge is currently trading at $38.20 after selling shares in its IPO at $32.

The tech IPO market has been showing signs of life, with Hinge being one of the latest offerings. On Thursday, shares of crypto company Circle Internet soared 168% in their New York Stock Exchange debut. Fintech company eToro started trading last month, and Chime Financial, which offers online banking services, is set to hit the market next week.

“Today is the right moment for us,” Duffy told CNBC’s “Squawk Box” on Friday. “We like the scale of the model, we like the scale of the business, equally we felt pull from the capital markets.”

Omada’s revenue increased 57% in its first quarter to $55 million from $35.1 million a year earlier, according to its prospectus. For 2024, revenue rose 38% to $169.8 million from $122.8 million the previous year. The company’s net loss narrowed to $9.4 million in the first quarter from $19 million a year ago.

U.S. Venture Partners, Andreessen Horowitz and Fidelity’s FMR LLC are the largest outside shareholders in the company, each owning between 9% and 10% of the stock.

WATCH: Jim Breyer on investing in circle over a decade ago

Jim Breyer on investing in Circle over a decade ago and the company's IPO debut



Source

SoftBank CEO says he’s ‘all in’ on OpenAI, reveals he’s long wanted Microsoft’s spot as main backer
Technology

SoftBank CEO says he’s ‘all in’ on OpenAI, reveals he’s long wanted Microsoft’s spot as main backer

Masayoshi Son, chairman and chief executive officer of SoftBank Group Corp., speaks during the company’s annual general meeting in Tokyo, Japan, on Friday, June 27, 2025. Bloomberg | Bloomberg | Getty Images SoftBank is “all in” on OpenAI, CEO Masayoshi Son said on Friday, as the Japanese tech giant looks to realize its vision of […]

Read More
SpaceX crane collapse in Texas being investigated by OSHA
Technology

SpaceX crane collapse in Texas being investigated by OSHA

The SpaceX Starbase industrial complex and rocket launch facility in Boca Chica, Texas, US, on Thursday, April 17, 2025. Mark Felix | Bloomberg | Getty Images A SpaceX crane collapse at the company’s Starbase, Texas facility on Tuesday has prompted an investigation by the Occupational Safety and Health Administration, the federal agency told CNBC in […]

Read More
Core Scientific shares surge 33% on report of buyout talks with CoreWeave
Technology

Core Scientific shares surge 33% on report of buyout talks with CoreWeave

Piotr Swiat | Lightrocket | Getty Images Core Scientific shares surged 35% on Thursday following a report from The Wall Street Journal that artificial intelligence infrastructure vendor CoreWeave is in talks to acquire the bitcoin mining and hosting provider. The company’s stock was briefly halted after the report, and then proceeded to have its second-sharpest […]

Read More